Literature DB >> 22067258

Body mass index at 11-13 weeks' gestation and pregnancy complications.

Argyro Syngelaki1, Foteini E Bredaki, Eirini Vaikousi, Nerea Maiz, Kypros H Nicolaides.   

Abstract

OBJECTIVE: To examine the association between body mass index (BMI) at 11-13 weeks' gestation and a wide range of adverse pregnancy outcomes after adjustment for confounding factors in obstetric history and maternal characteristics.
METHODS: This was a prospective screening study for adverse obstetric outcomes in women with singleton pregnancies attending for their first routine hospital visit at 11(+0)-13(+6) weeks of gestation. The maternal weight and height were measured and the BMI was calculated. Regression analysis was performed to examine the association between BMI and each of the adverse pregnancy outcomes.
RESULTS: We examined 41,577 pregnancies with a live fetus at 11-13 weeks. There was a significant contribution from maternal BMI, in addition to maternal characteristics and obstetric history, in the prediction of subsequent miscarriage, stillbirth, preeclampsia, gestational hypertension, gestational diabetes mellitus, delivery of small and large for gestational age neonates, and both elective and emergency cesarean section, but not spontaneous preterm delivery. The risk for each pregnancy complication increased exponentially with BMI, except for delivery of small for gestational age neonates which decreased with BMI.
CONCLUSIONS: Maternal BMI at 11-13 weeks can be combined with other maternal characteristics and obstetric history to estimate patient-specific risks for many pregnancy complications.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22067258     DOI: 10.1159/000328083

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  14 in total

1.  Early pregnancy waist-to-hip ratio and risk of preeclampsia: a prospective cohort study.

Authors:  Mahboubeh Taebi; Zohreh Sadat; Farzaneh Saberi; Masoumeh Abedzadeh Kalahroudi
Journal:  Hypertens Res       Date:  2014-09-04       Impact factor: 3.872

2.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

3.  THE PREVALENCE OF UNDERWEIGHT, OVERWEIGHT AND OBESITY IN A ROMANIAN POPULATION IN THE FIRST TRIMESTER OF PREGNANCY - CLINICAL IMPLICATIONS.

Authors:  A M Panaitescu; D Rotaru; I Ban; G Peltecu; A M Zagrean
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

4.  Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin.

Authors:  Jyoti Balani; Steve Hyer; Argyro Syngelaki; Ranjit Akolekar; Kypros H Nicolaides; Antoinette Johnson; Hassan Shehata
Journal:  Obstet Med       Date:  2017-10-16

5.  Levels of key enzymes of methionine-homocysteine metabolism in preeclampsia.

Authors:  Alejandra Pérez-Sepúlveda; Pedro P España-Perrot; Ximena B Fernández; Verónica Ahumada; Vicente Bustos; José Antonio Arraztoa; Aneta Dobierzewska; Horacio Figueroa-Diesel; Gregory E Rice; Sebastián E Illanes
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

6.  Prognostic risk factors for early diagnosing of Preeclampsia in Nulliparas.

Authors:  Morteza Ghojazadeh; Saber Azami-Aghdash; Marziye Mohammadi; Shohre Vosoogh; Sahar Mohammadi; Mohammad Naghavi-Behzad
Journal:  Niger Med J       Date:  2013-09

7.  Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.

Authors:  Laura A Magee; Peter von Dadelszen; Joel Singer; Terry Lee; Evelyne Rey; Susan Ross; Elizabeth Asztalos; Kellie E Murphy; Jennifer Menzies; Johanna Sanchez; Amiram Gafni; Andrée Gruslin; Michael Helewa; Eileen Hutton; Shoo K Lee; Alexander G Logan; Wessel Ganzevoort; Ross Welch; Jim G Thornton; Jean Marie Moutquin
Journal:  Acta Obstet Gynecol Scand       Date:  2016-04-07       Impact factor: 3.636

8.  Effect of metformin on maternal and neonatal outcomes in pregnant obese non-diabetic women: A meta-analysis.

Authors:  Ahmed Elmaraezy; Abdelrahman Ibrahim Abushouk; Amany Emara; Omar Elshahat; Hussien Ahmed; Magdy I Mostafa
Journal:  Int J Reprod Biomed (Yazd)       Date:  2017-08

9.  Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects.

Authors:  Rolf Becker; Thomas Keller; Holger Kiesewetter; Heiner Fangerau; Uta Bittner
Journal:  Arch Gynecol Obstet       Date:  2013-02-07       Impact factor: 2.344

10.  Physical activity and excess weight in pregnancy have independent and unique effects on delivery and perinatal outcomes.

Authors:  Kelly L Morgan; Muhammad A Rahman; Rebecca A Hill; Shang-Ming Zhou; Gunnar Bijlsma; Ashrafunnesa Khanom; Ronan A Lyons; Sinead T Brophy
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.